(Q40421566)

English

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of he

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of he (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

H Toyoda

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

T Tada

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

K Takaguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

T Senoh

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

N Shimada

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

A Hiraoka

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

K Michitaka

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

T Ishikawa

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

T Kumada

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

16 December 2016

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

472-476

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Viral hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12665

21 January 2018

Identifiers

10.1111/JVH.12665

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40421566&oldid=1540646181"